Effect of rhubarb in diabetes type 2
Not Applicable
- Conditions
- Diabetes type 2.Insulin-dependent diabetes mellitus, Non-insulin-dependent diabetes mellitus, Malnutrition-related diabetes mellitus, Other specified diabetes mellitus, Unspecified diabetes mellitusE10, E11,
- Registration Number
- IRCT201410142709N31
- Lead Sponsor
- Vice Chancellor for research, Iran University of Medical Sciences,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
30-60-year old patients with fasting blood glucose of greater than 126 mg/dl are included in the project.
Exclusion criteria: Patients with hyperglycemia caused by diseases other than diabetes, patients suffering from liver, thyroid and kidney diseases, patients being treated with insulin, taking ß-blockers and lipid-lowering drugs, consuming alcoholic drinks, having severe, acute, active infectious diseases when blood samples are taken, and patients who are hospitalized during the study are excluded from the study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Body Mass Index. Timepoint: Before and 6 weeks after intervention. Method of measurement: SECA,Kilogram per meter Square.;Malondialdehyde. Timepoint: Before intervention and 6 weeks after intervention. Method of measurement: Spectrophotometry, mmol/L.;High sensitivity c-reactive protein. Timepoint: Before and 6 weeks after intervention. Method of measurement: immunoturbidimetry, mg/dl.;Fasting Blood Sugar. Timepoint: Before and 6 weeks after intervention. Method of measurement: glucose oxsidase , mg/dl.;Apolipoprotein B. Timepoint: Before and 6 weeks after intervention. Method of measurement: immunoturbidimetry, mg/dl.;Apolipoprotein A1. Timepoint: Before and 6 weeks after intervention. Method of measurement: immunoturbidimetry, mg/dl.;Insulin level. Timepoint: Before and 6 weeks after intervention. Method of measurement: enzymatic, mg/dl.
- Secondary Outcome Measures
Name Time Method Blood Pressure. Timepoint: Before and 6 weeks after intervention. Method of measurement: Mercury Sphygmomanometer, mmHg.